Tue, Dec 27, 2022 page11

• Taiwan Business Quick Take

  • Staff writer, with CNA
  • • 
    • 
    • 

  PHARMACEUTICALS

  Biotech shares in demand

  The biotechnology sector on the local main board yesterday rose 1.89 percent, compared with the TAIEX’s 0.09 percent increase, as investors continued to buy biotech stocks on expectations that an outbreak of COVID-19 in China would push up demand for drugs. “But the gains were mainly driven by expectations,” Concord Capital Management Corp (康和投顧) analyst Lu Chin-wei (呂晉維) said, adding that the expectations also lifted the biotech sector on the over-the-counter market by 1.23 percent. However, the gains might be short-lived, as “investors still want to see real sales numbers to back up the expectations,” Lu said. Among biotech stocks, China Chemical & Pharmaceutical Co (中化製藥), Chunghwa Chemical Synthesis & Biotech Co (中化合成生技) and Sinphar Pharmaceutical Co (杏輝藥品) soared 10 percent, the maximum daily increase.

  EQUITIES

  Foreigners are net sellers

  Foreign investors last week sold a net NT$31.42 billion (US$1.02 million) of local shares after selling a net NT$18.46 billion the previous week, the Taiwan Stock Exchange said in a statement yesterday. As of Friday, foreign investors had sold NT$1.21 trillion of local shares since the beginning of the year, it said. The top three shares sold by foreign investors last week were SinoPac Financial Holdings Co (永豐金控), CTBC Financial Holding Co (中信金控) and Yuanta Financial Holding Co (元大金控), while the top three shares bought by foreign investors were China Steel Corp (中鋼), Taiwan Cement Corp (台灣水泥) and Yang Ming Marine Transport Corp (陽明海運). As of Friday, the market capitalization of shares held by foreign investors was NT$17.72 trillion, or 39.75 percent of total market capitalization, the exchange said.

  INSURANCE

  Tokio Marine injects capital

  Japan’s Tokio Marine & Nichido Fire Insurance Co has won the Investment Commission’s permission to inject fresh capital into its Taiwanese unit in light of rising claims for COVID-19 insurance policies. The Japanese firm is to inject NT$2.66 billion into Tokio Marine Newa Insurance Corp (新安東京海上產險) to increase the local unit’s working capital and in response to rising payouts for COVID-19 insurance policies, the commission said in a statement. The commission also approved Denmark’s Orsted Wind Power TW Holding A/S injecting NT$11.99 billion into Greater Changhua Offshore Wind Farm NW Ltd (大彰化西北離岸風力發電) for its offshore wind projects in Taiwan, it added.

  PROPERTY

  Huaku sells Taipei complex

  Luxury housing developer Huaku Development Co (華固建設) yesterday said it sold a commercial complex, which is under construction in the Beitou Shilin Science Park (北投士林科技園區) in Taipei, to BAM Asset Management Co (寶元開發) for NT$4.59 billion. The Huaku Trade and Finance Center (華固樂富中心) project is composed of an office building with 14 floors above ground and four basement floors on about 6,185 ping (20,446m2) of land, as well as 135 parking spaces, Huaku said in a regulatory filing. The unit price of the sale is about NT$694,200 per ping, it said. Construction of the complex is expected to be completed in September or October, the company said, without specifying the potential gains from the sale. The company reported revenue of NT$14.46 billion in the first three quarters of the year, or earnings per share of NT$10.9. BAM Asset Management is a property development unit of textile maker Jang Dah Nylon Industrial Corp (正大尼龍).
• Most Popular

  • 1

    Taiwan to keep advanced chip tech

  • 2

    Taiwan’s fall would be a ‘disaster’: Colby

  • 3

    TSMC won’t produce 2nm chips in US next year: Kuo

  • 4

    Actor Darren Wang questioned over attack of cab driver

  • 5

    Taiwan rejects China’s UN claim